NEU neuren pharmaceuticals limited

Ann: Q2 2024 update, page-59

  1. 3,217 Posts.
    lightbulb Created with Sketch. 723
    Bigb888
    I am the first to admit that I may well use the term retention rate in a sense which may not coincide with the medical definition of same.Similarly pesistency rate and others are not my strong point.However if you are looking for revenue generation- numbers like patients on therapy are an important factor.Using Acadia's own $375000 net revenue per patient estimate 900 patients on therapy for a full year will produce about $338M in revenue. If something like 66 patients are said to be added each month and patients on therapy is not rising much revenue estimates become extremely difficult.I trust I am making some sense here.
    Kens
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.612B
Open High Low Value Volume
$13.20 $13.36 $12.82 $4.627M 354.8K

Buyers (Bids)

No. Vol. Price($)
1 7585 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$13.03 3344 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.